Skip to content
Open access

Utilising speech-derived biomarkers to detect Alzheimer's disease with BERT-based language models: a machine learning study

Aug 2026 · Frontiers in Artificial Intelligence · Vol 9 · 0 citations · 37 references
Medicine

TL;DR

Pauses emerged as the most discriminatory speech biomarker, significantly outperforming the No-biomarker baseline and other biomarkers, though the effect was model-dependent: BERT's All-biomarkers condition exceeded its own No-biomarker baseline, suggesting that feature combination benefits higher-capacity models.

Abstract

Background Early diagnosis is critical for effective management of Alzheimer's disease (AD). While prior studies have shown that speech features can be indicative of AD, most existing work consolidates multiple biomarkers, making it difficult to isolate the contribution of individual features. Objective This study systematically isolates individual speech biomarkers to quantify their distinct contributions to AD classification performance of language models (LMs) and determine whether targeted biomarker selection improves over consolidated feature sets. Methods We processed speech transcriptions from DementiaBank to surface discriminatory speech biomarkers—verbal pauses, disfluencies, and unintelligible words. We then fine-tuned and evaluated lightweight LMs (BERT, AlBERT, and DistilBERT) on these biomarker-conditioned transcripts for automatic AD classification. Results Pauses emerged as the most discriminatory speech biomarker (F1 = 0.8326), significantly outperforming the No-biomarker baseline and other biomarkers. Combining all biomarkers degraded performance relative to pauses alone on average across models, though the effect was model-dependent: BERT's All-biomarkers condition exceeded its own No-biomarker baseline, suggesting that feature combination benefits higher-capacity models. BERT yielded the best performance (F1 = 0.8154) across conditions. Conclusions Selective use of speech biomarkers such as pauses can meaningfully improve AD detection with lightweight LMs, suggesting that targeted biomarker selection may offer a more interpretable and clinically actionable path than broad feature consolidation.

Read PDF

Similar papers

Conference

Enhancing Early Dementia Detection with AI and Character-Level Speech Biomarkers

The rising prevalence of neurocognitive disorders, such as Alzheimer’s disease (AD), poses a significant global health challenge. Traditional diagnostic methods, including clinical interviews and paper-based tests like the Mini-Mental State Examination (MMSE), Mini-Cog Test, and Montreal Cognitive Assessment (MoCA), ar...

K. Mekulu, Hui Yang, Faisal Aqlan · 0 citations
Open access Sep 2026

Application of unsupervised and supervised machine learning approaches to blood-based biomarkers of Alzheimer’s disease in a memory clinic cohort

Blood-based biomarkers (BBMs) are promising tools to facilitate biological diagnosis of Alzheimer’s Disease (AD). Establishing reliable cutoffs for BBMs represents a major issue for real-world implementation and the investigation of combined BBM approaches is limited. Our aim is to test different machine learning...

Edoardo Guido Torrigiani, D. Cianca, L. Gaetani et al. · 0 citations
Review Open access Sep 2026

Artificial Intelligence-Related Voice and Speech Biomarkers of Alzheimer's Disease: A Systematic Review.

BACKGROUND Artificial intelligence (AI)-based voice and speech analysis is emerging as a promising, noninvasive biomarker for Alzheimer's disease (AD) and mild cognitive impairment (MCI). This study aimed to systematically review AI voice and speech models for detecting AD and MCI, and to evaluate their translational p...

Samantha Mairesse, Giovanni Briganti, J. R. Lechien · 0 citations
Open access Aug 2026

Interpretable multimodal learning for integrating neuroimaging and genetic data in Alzheimer’s disease

R-GenIMA, an interpretable multimodal large language model that pairs a region-of-interest vision transformer with genetic prompting to jointly analyze structural MRI and single nucleotide polymorphisms, shows that interpretable multimodal AI can integrate imaging and genetics to reveal disease mechanisms.

Kun Zhao, Si-Yuan Dai, Ying-Ying Zhang et al. · 0 citations
Open access Aug 2026

Speech-Based Alzheimer's Detection Under Controlled Acoustic Perturbations: A Baseline Study of Class Imbalance and Robustness

Background: Alzheimer's disease (AD) affects over 55 million people worldwide, and early detection through speech analysis offers a low-cost, non-invasive alternative to neuroimaging. However, clinical deployment of speech-based classifiers faces underexplored challenges: domain shifts across recording environments, li...

A. Singh · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.